<DOC>
	<DOCNO>NCT01490801</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research trial study biomarkers blood tissue sample patient Epstein-Barr virus positive Hodgkin lymphoma .</brief_summary>
	<brief_title>Biomarkers Blood Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate germline DNA patient Epstein-Barr virus positive ( EBV+ ) Hodgkin lymphoma ( HL ) inducible T-cell kinase ( ITK ) mutation . - Examine effect ITK mutation expression ITK protein . - Determine whether ITK mutation correlate specific clinical histopathological feature HL . OUTLINE : Archived blood tumor tissue sample analyze germline DNA expression inducible T-cell kinase ( ITK ) mutation PCR , IHC , flow cytometry , western blotting , EBV-encoded RNA ( EBER ) use situ hybridization . Each patient 's data , date , sex , age , tumor stage histology diagnosis , treatment receive , response treatment , development recurrent disease , date last follow-up , outcome also collect .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis Hodgkin lymphoma ( HL ) meeting follow criterion : EpsteinBarr viruspositive ( EBV+ ) HL assess positive EBV serology , elevate level EBV genome blood tumor tissue follow quantitative polymerase chain reaction ( PCR ) and/or evidence EBV positivity pathology sample ( EBER+ LMP+ ) , possible , mixed cellular histology Young age ( &lt; 10 year ) diagnosis Presence hemophagocytic lymphohistiocytosis ( HLH ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood Hodgkin lymphoma</keyword>
	<keyword>childhood mixed cellularity Hodgkin lymphoma</keyword>
	<keyword>hemophagocytic lymphohistiocytosis</keyword>
	<keyword>Epstein-Barr virus infection</keyword>
</DOC>